Desmoid is not a sarcoma; reply to Sachdev et al.
作者信息
van der Graaf Winette T A, Husson Olga, van Houdt Winan J
机构信息
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Department of Medical Oncology, ErasmusMC Cancer, Institute, Rotterdam, the Netherlands.
出版信息
EClinicalMedicine. 2023 Feb 15;56:101851. doi: 10.1016/j.eclinm.2023.101851. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Desmoid is not a sarcoma; reply to Sachdev et al.硬纤维瘤并非肉瘤；对萨赫德夫等人的回应
EClinicalMedicine. 2023 Feb 15;56:101851. doi: 10.1016/j.eclinm.2023.101851. eCollection 2023 Feb.
2
Reply to Sachdev et al.对萨赫德夫等人的回复
Clin Infect Dis. 2014 Jun;58(12):1788. doi: 10.1093/cid/ciu231. Epub 2014 Apr 12.
3
Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.发生于硬纤维瘤病的放射性肉瘤并非总是起源于原发性肿瘤。
Am J Surg Pathol. 2015 Dec;39(12):1701-7. doi: 10.1097/PAS.0000000000000510.
4
Desmoid tumor mimics local recurrence of extremity sarcoma on MRI.磁共振成像上，硬纤维瘤酷似肢体肉瘤的局部复发。
J Surg Oncol. 2020 Jun;121(8):1259-1265. doi: 10.1002/jso.25906. Epub 2020 Mar 24.
5
High-grade soft tissue sarcoma arising in a desmoid tumor: case report and review of the literature.硬纤维瘤中发生的高级别软组织肉瘤：病例报告及文献复习
Clin Sarcoma Res. 2015 Nov 30;5:25. doi: 10.1186/s13569-015-0040-0. eCollection 2015.
6
Are the Pieces Starting to Come Together for Management of Desmoid Tumors?纤维瘤病的治疗是否开始渐入佳境？
Clin Cancer Res. 2022 Sep 15;28(18):3911-3913. doi: 10.1158/1078-0432.CCR-22-0620.
7
Nationwide trends in the current management of desmoid (aggressive) fibromatosis.硬纤维瘤（侵袭性纤维瘤病）当前治疗的全国性趋势。
Clin Oncol (R Coll Radiol). 2015 Jun;27(6):362-8. doi: 10.1016/j.clon.2015.02.006. Epub 2015 Feb 28.
8
An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).关于散发性硬纤维瘤样纤维瘤病（desmoid-type fibromatosis）治疗的最新进展：肉瘤患者欧洲网络（Sarcoma PAtients EuroNet，SPAEN）和欧洲癌症研究与治疗组织（European Organization for Research and Treatment of Cancer，EORTC）/软组织和骨肿瘤研究组（Soft Tissue and Bone Sarcoma Group，STBSG）之间的欧洲共识倡议。
Ann Oncol. 2017 Oct 1;28(10):2399-2408. doi: 10.1093/annonc/mdx323.
9
Chubukov and Sachdev reply.楚布科夫和萨赫德夫回复。
Phys Rev Lett. 1993 Nov 22;71(21):3615. doi: 10.1103/PhysRevLett.71.3615.
10
CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.CTNNB1 突变分析是诊断韧带样瘤的有用工具：260 例韧带样瘤和 191 例潜在形态模拟物的研究。
Mod Pathol. 2012 Dec;25(12):1551-8. doi: 10.1038/modpathol.2012.115. Epub 2012 Jul 6.
本文引用的文献
1
Objective response rate of placebo in randomized controlled trials of anticancer medicines.抗癌药物随机对照试验中安慰剂的客观缓解率。
EClinicalMedicine. 2022 Nov 24;55:101753. doi: 10.1016/j.eclinm.2022.101753. eCollection 2023 Jan.
2
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.《韧带样纤维瘤的治疗管理：成人和儿童患者基于全球共识的联合指南方法》
Eur J Cancer. 2020 Mar;127:96-107. doi: 10.1016/j.ejca.2019.11.013. Epub 2020 Jan 28.
3
Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance.所有解剖部位的原发性韧带样瘤在主动监测下的初始治疗结果。
Ann Surg Oncol. 2019 Dec;26(13):4699-4706. doi: 10.1245/s10434-019-07826-6. Epub 2019 Sep 17.
4
Sorafenib for Advanced and Refractory Desmoid Tumors.索拉非尼治疗晚期和难治性硬纤维瘤。
N Engl J Med. 2018 Dec 20;379(25):2417-2428. doi: 10.1056/NEJMoa1805052.
5
Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care?从患者角度看韧带样纤维瘤病：是否需要改变关注焦点和护理组织形式？
Support Care Cancer. 2019 Mar;27(3):965-980. doi: 10.1007/s00520-018-4386-8. Epub 2018 Aug 28.
Zotero 插件